NCT07162480 2026-03-09Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)M.D. Anderson Cancer CenterPhase 2 Not yet recruiting28 enrolled